
    
      The purpose of the study was to assess the response rate in children and young adults with
      ALL/LBL and hypersensitivity to pegaspargase defined as the proportion of subjects having a
      serum asparaginase activity (SAA) level of â‰¥ 0.1 IU/mL 14 days following the first IV
      pegcrisantaspase dose in Course 1. Also, to assess the safety of IV pegcrisantaspase therapy
      in children and young adults with ALL/LBL with hypersensitivity to pegaspargase.
    
  